ERNA - Eterna Therapeutics Inc.
0.285
-0.022 -7.719%
Share volume: 501,811
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$0.31
-0.02
-0.07%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 03-12-2025 | 05-07-2025 | 08-13-2025 | 11-07-2025 | |
| Cash flow financing | 1.010 M | 2.254 M | 4.929 M | 26.000 K | |
| Other financing cash flows | -34.000 K | 4.000 K | 0.000 | 26.000 K | |
| Cash flow | 0.000 | 189.000 K | 0.000 | -1.268 M | |
| Net income | -5.759 M | -8.202 M | -3.139 M | -1.240 M | |
| Depreciation | 19.000 K | 18.000 K | 17.000 K | 17.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | -22.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 8.000 K | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 22.000 K | |
| Cash Change | -2.535 M | 189.000 K | 2.397 M | -1.268 M |